Author: Miyssa I. Abdelmageed; Abdelrahman H. Abdelmoneim; Mujahed I. Mustafa; Nafisa M. Elfadol; Naseem S. Murshed; Shaza W. Shantier; Abdelrafie M. Makhawi
Title: Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach Document date: 2020_2_11
ID: 6ojmmmuj_46
Snippet: Designing of a novel vaccine is very crucial to defending the rapid endless of global burden of disease [56] [57] [58] [59] . In the last few decades, biotechnology has advanced rapidly; alongside with the understanding of immunology which assisted the rise of new approaches towards rational vaccines design [60] . Peptide-based vaccines are designed to elicit immunity particular pathogens by selectively stimulating antigen specific for B and T ce.....
Document: Designing of a novel vaccine is very crucial to defending the rapid endless of global burden of disease [56] [57] [58] [59] . In the last few decades, biotechnology has advanced rapidly; alongside with the understanding of immunology which assisted the rise of new approaches towards rational vaccines design [60] . Peptide-based vaccines are designed to elicit immunity particular pathogens by selectively stimulating antigen specific for B and T cells [61] .Applying the advanced bioinformatics tools and databases, various peptide-based vaccines could be designed where the peptides act as ligands [62] [63] [64] . This approach has been used frequently in Saint Louis encephalitis virus [65] , dengue virus [66] , chikungunya virus [67] proposing promising peptides for designing vaccines.
Search related documents:
Co phrase search for related documents- chikungunya virus and encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- chikungunya virus and global burden: 1, 2, 3
- chikungunya virus and new approach: 1
- chikungunya virus and novel vaccine: 1, 2, 3, 4, 5, 6
- chikungunya virus and Saint Louis encephalitis virus: 1, 2
- chikungunya virus and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8
- dengue virus and disease global burden: 1, 2
- dengue virus and encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- dengue virus and global burden: 1, 2, 3, 4, 5, 6
- dengue virus and new approach: 1, 2, 3
- dengue virus and novel vaccine: 1, 2, 3, 4, 5, 6, 7, 8
- dengue virus and Saint Louis encephalitis virus: 1, 2
- dengue virus and vaccine design: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- disease global burden and global burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- disease global burden and novel vaccine: 1, 2, 3, 4
- disease global burden and rational vaccine design: 1
- disease global burden and vaccine design: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date